This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
Orders and Observations Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile DiagnosticReport-Genetics (FHIR Specification Core)).
Gene DNAVariation Status Interpretation BRCA1 Negative BRCA2 185delAG Positive Pathogenic
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Issued: 2015-05-26T15:30:10+01:00
FamilyMemeberHistory: Mother
Gene DNAVariation Status BRCA2 185delAG Positive
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.